Eur Rev Med Pharmacol Sci 2023; 27 (5 Suppl): 86-94DOI: 10.26355/eurrev_202310_34076 Elevated serum lactate dehydrogenase to albumin ratio is a useful poor prognostic predictor of nivolumab in patients with non-small cell lung cancer S. Menekse, E. Kut, E. Almuradova Published on: 2023/10/20 Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (5): 2068-2076DOI: 10.26355/eurrev_202303_31578 Risk factors for delirium among patients with advanced cancer in palliative care: a multicenter, patient-based registry cohort in South Korea S.W. Lee, E.H. Jung, H.J. Kim, C. Min, S.H. Yoo, Y.J. Kim, S.Y. Rha, D.K. Yon, B. Kang Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (5): 2060-2067DOI: 10.26355/eurrev_202303_31577 The relationship between hemoglobin-RDW ratio and clinical outcomes in patients with advanced pancreas cancer A. İlhan, F. Gurler, F. Yilmaz, E. Eraslan, M. Dogan Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (5): 2052-2059DOI: 10.26355/eurrev_202303_31576 Wide surgical margins improve prognosis for HCC with microvascular invasion W.-D. Lin, L.-N. Ye, Z.-S. Song, K.-P. Wang, Y.-F. Feng, C.-Y. Pan Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (5): 2047-2051DOI: 10.26355/eurrev_202303_31575 Knowledge and attitude of radiation safety and the use of protective measures among healthcare workers in a tertiary center A.M. Alkhayal, A.S. Alothman, A.H. Alathel, A. AlMaslamani, O.N. Alfehaid, I.A. Alhassan, K.A. Alrabeeah, Y.G. Ghazwani Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (5): 2027-2046DOI: 10.26355/eurrev_202303_31569 Potential biomarkers for the prognosis and treatment of HCC immunotherapy H. Li, Q. He, G.-M. Zhou, W.-J. Wang, P.-P. Shi, Z.-H. Wang Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (4): 1503-1511DOI: 10.26355/eurrev_202302_31391 Vorinostat induces G2/M cell cycle arrest in breast cancer cells via upregulation of PTEN A.I. Alqosaibi, S. Abdel-Ghany Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (4): 1494-1502DOI: 10.26355/eurrev_202302_31390 Efficacy and safety of PD1/PDL1 inhibitors combined with radiotherapy and antiangiogenic drugs for hepatocellular carcinoma: a systematic review and meta-analysis F. Xian, J. Wu, Y.-L. Yuan, J. Bie, G.-H. Xu Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (4): 1487-1493DOI: 10.26355/eurrev_202302_31389 Daidzein alleviated the pathologies in intestinal tissue against ischemia-reperfusion C. Durgun, F. Aşır Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (4): 1480-1486DOI: 10.26355/eurrev_202302_31388 Relationship between PET/CT images and KRAS gene mutations in colorectal cancer in Vietnamese patients N.V. Dan, P.C. Phuong, P.V. Thai, N.H. Nguyen, N.T. Loi, B.T. Cong Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (4): 1474-1479DOI: 10.26355/eurrev_202302_31387 Serum irisin levels in colorectal cancer patients Z. Celik, N.K. Baygutalp, A.F. Kilic, S.B. Tekin, E. Bakan, M.A. Gul, N. Yuce Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (4): 1443-1449DOI: 10.26355/eurrev_202302_31384 Microbiota-derived metabolites in colorectal cancer patients in preoperative period K. Kaźmierczak-Siedlecka, K. Skonieczna-Żydecka, J. Palma, B.K. Sobocki, M. Świerblewski, K. Siedlecka-Kroplewska, L. Kalinowski, K. Połom Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (4): 1229-1229DOI: 10.26355/eurrev_202302_31353 Retraction Note: MicroRNA-375 accelerates the invasion and migration of colorectal cancer through targeting RECK L.-J. Wei, D.-M. Bai, Z.-Y. Wang, B.-C. Liu Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (3): 1134-1139DOI: 10.26355/eurrev_202302_31219 Breakthrough pain in patients with multiple myeloma: a secondary analysis of IOPS MS study S. Mercadante, A. Caraceni, A. Cuomo, M. Mammucari, P. Marchetti, R.D. Mediati, S. Natoli, G. Tonini Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (3): 1128-1133DOI: 10.26355/eurrev_202302_31218 The survival of the prostate cancer patients with secondary colorectal cancer: a study based on a SEER database from southern China L. Lin, L. Huang, Y.-L. Li, H. Shan Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (3): 1121-1127DOI: 10.26355/eurrev_202302_31215 The analysis of oral nutritional supplements related aspects among patients with digestive system cancer K. Kaźmierczak-Siedlecka, E. Stachowska, B. Sobocki, M. Świerblewski, J. Jędrzejczak, K. Połom Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (3): 911-923DOI: 10.26355/eurrev_202302_31184 Comparative clinical outcomes and predictive biomarkers of sintilimab combinations vs. single therapy in cancer: a systematic review and meta-analysis of randomized controlled trials J. Li, X.-Y. Zang, Z. Dai Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (3): 834-834DOI: 10.26355/eurrev_202302_31171 Long noncoding RNA ITGB1 promotes migration and invasion of clear cell renal cell carcinoma by downregulating Mcl-1 X.-L. Zheng, Y.-Y. Zhang, W.-G. Lv Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (2): 713-727DOI: 10.26355/eurrev_202301_31074 Role of sphingosine-1-phosphate receptors in the tumor microenvironment: prospects for cancer immunotherapy Z. Wang, H.-M. Zhang, Y.-R. Guo, L.-L. Li, G.-Z. Zhang Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (2): 704-712DOI: 10.26355/eurrev_202301_31073 Factors affecting anxiety, depression, and stress among patients with hepatocellular carcinoma during COVID-19 pandemic S. Akbulut, M. Tamer, Z. Kucukakcali, M. Akyuz, H. Saritas, N. Bagci, F. Ciftci, M.S. Akbulut, E. Karabulut, S. Yilmaz Free PDF Download